INCA 32459-101: A Phase 1, Open-Label, Multicenter Study of INCA32459 in Participants With Select Advanced Malignancies

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-501505-13-00

Acronym

INCA 32459-101

Enrollment

140

Registered

2023-02-17

Start date

2023-03-31

Completion date

2025-09-23

Last updated

2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffuse large B-cell lymphoma, Metastatic melanoma, Neoplasm malignant, Primary mediastinal large B-cell lymphoma, Squamous cell carcinoma of head and neck

Interventions

None listed

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Countries

Belgium, France, Italy, Spain

Outcome results